Autologous Stem/Stromal Cells in Neurological Disorders and Disease
Public ClinicalTrials.gov record NCT03297177. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Use Of Autologous Stem Cell Use In Neurological Non-neoplastic Disorders And Disease
Study identification
- NCT ID
- NCT03297177
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Regeneris Medical
- Other
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
- Microcannula Harvest Adipose Procedure
- Centricyte 1000 Device
- Sterile Normal Saline Infusion Procedure
Procedure · Device
Eligibility (public fields only)
- Age range
- 18 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2019
- Primary completion
- Dec 31, 2022
- Completion
- Dec 31, 2022
- Last update posted
- Oct 17, 2018
2020 – 2023
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Regeneris Medical Inc | North Attleboro | Massachusetts | 02760 | — |
| Regeneris Medical | North Attleboro | Massachusetts | 02760 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03297177, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 17, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03297177 live on ClinicalTrials.gov.